Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153677 | SCV000203234 | uncertain significance | not provided | 2014-04-15 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000666199 | SCV000790452 | uncertain significance | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-03-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000666199 | SCV002789175 | uncertain significance | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002516088 | SCV003441909 | uncertain significance | Peroxisome biogenesis disorder 3A (Zellweger) | 2021-09-01 | criteria provided, single submitter | clinical testing | This variant occurs in a non-coding region of the PEX12 gene. It does not change the encoded amino acid sequence of the PEX12 protein. This variant is present in population databases (rs727504080, ExAC 0.001%). This variant has been observed in individual(s) with Zellweger spectrum disorder (PMID: 26643206). ClinVar contains an entry for this variant (Variation ID: 167450). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Seelig Lab, |
RCV000153677 | SCV000897889 | not provided | not provided | no assertion provided | in vitro |